Activity Info

The prevalence of atopic dermatitis (AD) in industrialized nations is estimated at up to 30% for children and up to 10% for adults. The vast majority (85%) of affected patients develop symptoms before reaching their 5th birthday. For children, severity can increase with age although in 70% of childhood cases AD remits by adolescence. Allergist/immunologists often receive referrals of these challenging cases from other clinicians, and it is essential that they and the other healthcare providers working with them be prepared to provide optimal treatment to these patients.

To clarify these challenges, the American Academy of Allergy, Asthma & Immunology and The France Foundation have designed a certified medical education initiative through which non-dermatology specialists can increase their knowledge, confidence and competence in the diagnosis, assessment and treatment of patients with AD. This activity will highlight the diagnosis and treatment of AD in infants and children.